{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T02:37:12Z","timestamp":1790390232796,"version":"4.1.0"},"update-to":[{"DOI":"10.1371\/journal.pntd.0006653","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2018,8,6]],"date-time":"2018-08-06T00:00:00Z","timestamp":1533513600000}}],"reference-count":26,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2018,7,25]],"date-time":"2018-07-25T00:00:00Z","timestamp":1532476800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Drugs for Neglected Diseases initiative (DNDi)"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0006653","type":"journal-article","created":{"date-parts":[[2018,7,25]],"date-time":"2018-07-25T17:25:10Z","timestamp":1532539510000},"page":"e0006653","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":54,"title":["A phase II study to evaluate the safety and efficacy of topical 3% amphotericin B cream (Anfoleish) for the treatment of uncomplicated cutaneous leishmaniasis in Colombia"],"prefix":"10.1371","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1790-6058","authenticated-orcid":true,"given":"Liliana","family":"L\u00f3pez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iv\u00e1n","family":"V\u00e9lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Asela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiana","family":"Alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Robledo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byron","family":"Arana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,7,25]]},"reference":[{"key":"ref1","unstructured":"World Health Organization (WHO) (2010) Control of the leishmaniasis. 202 p."},{"key":"ref2","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s40257-015-0114-z","article-title":"Cutaneous leishmaniasis: recent developments in diagnosis and management","volume":"16","author":"HJ de Vries","year":"2015","journal-title":"Am J Clin Dermatol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S1473-3099(07)70209-8","article-title":"Cutaneous leishmaniasis","volume":"7","author":"R Reithinger","year":"2007","journal-title":"Lancet Infect Dis"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"e35671","DOI":"10.1371\/journal.pone.0035671","article-title":"Leishmaniasis worldwide and global estimates of its incidence","volume":"7","author":"J Alvar","year":"2012","journal-title":"PLoS One"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1590\/S0102-311X2009000600015","article-title":"Epidemiology of American tegumentary leishmaniasis in the State of Acre, Brazilian Amazon","volume":"25","author":"NS Silva","year":"2009","journal-title":"Cad Saude Publica"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"807","DOI":"10.4269\/ajtmh.2012.11-0408","article-title":"An epidemic outbreak of canine cutaneous leishmaniasis in Colombia caused by Leishmania braziliensis and Leishmania panamensis","volume":"86","author":"ID Velez","year":"2012","journal-title":"Am J Trop Med Hyg"},{"key":"ref7","article-title":"Cost-effectiveness analysis of thermotherapy versus pentavalent antimonials for the treatment of cutaneous leishmaniasis","author":"JA Cardona-Arias","year":"2017","journal-title":"J Evid Based Med"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1056\/NEJM199203123261105","article-title":"Allopurinol in the treatment of American cutaneous leishmaniasis","volume":"326","author":"S Martinez","year":"1992","journal-title":"N Engl J Med"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"269515","DOI":"10.1155\/2011\/269515","article-title":"Comparison of oral zinc sulfate with systemic meglumine antimoniate in the treatment of cutaneous leishmaniasis","volume":"2011","author":"MJ Yazdanpanah","year":"2011","journal-title":"Dermatol Res Pract"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4269\/ajtmh.2010.09-0287","article-title":"A controlled, randomized-blinded clinical trial to assess the efficacy of a nitric oxide releasing patch in the treatment of cutaneous leishmaniasis by Leishmania (V.) panamensis","volume":"83","author":"P Lopez-Jaramillo","year":"2010","journal-title":"Am J Trop Med Hyg"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"351","DOI":"10.4269\/ajtmh.2010.10-0060","article-title":"Efficacy of miltefosine for the treatment of American cutaneous leishmaniasis","volume":"83","author":"I Velez","year":"2010","journal-title":"Am J Trop Med Hyg"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/QCO.0000000000000194","article-title":"Leishmaniasis: treatment updates and clinical practice guidelines review","volume":"28","author":"NK Copeland","year":"2015","journal-title":"Curr Opin Infect Dis"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S1201-9712(03)90002-6","article-title":"Therapy of cutaneous leishmaniasis","volume":"7","author":"SA Lee","year":"2003","journal-title":"Int J Infect Dis"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"434","DOI":"10.4269\/ajtmh.2012.11-0682","article-title":"Leishmaniasis in the United States: treatment in 2012","volume":"86","author":"HW Murray","year":"2012","journal-title":"Am J Trop Med Hyg"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1590\/S0365-05962011000600005","article-title":"A randomized clinical trial comparing meglumine antimoniate, pentamidine and amphotericin B for the treatment of cutaneous leishmaniasis by Leishmania guyanensis","volume":"86","author":"LO Neves","year":"2011","journal-title":"An Bras Dermatol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1111\/j.1468-3083.2010.03908.x","article-title":"Liposomal amphotericin B treatment of cutaneous leishmaniasis due to Leishmania tropica","volume":"25","author":"M Solomon","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.jaad.2012.06.014","article-title":"Liposomal amphotericin B in comparison to sodium stibogluconate for Leishmania braziliensis cutaneous leishmaniasis in travelers","volume":"68","author":"M Solomon","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1371\/journal.pntd.0000034","article-title":"Optimization of topical therapy for Leishmania major localized cutaneous leishmaniasis using a reliable C57BL\/6 Model","volume":"1","author":"H Lecoeur","year":"2007","journal-title":"PLoS Negl Trop Dis"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1007\/s00436-017-5454-6","article-title":"Detection and identification of Leishmania spp.: application of two hsp70-based PCR-RFLP protocols to clinical samples from the New World","volume":"116","author":"AM Montalvo","year":"2017","journal-title":"Parasitol Res"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1007\/s10096-011-1463-z","article-title":"Three new sensitive and specific heat-shock protein 70 PCRs for global Leishmania species identification","volume":"31","author":"AM Montalvo","year":"2012","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1128\/JCM.38.10.3768-3773.2000","article-title":"Diagnosis of cutaneous leishmaniasis in Colombia: the sampling site within lesions influences the sensitivity of parasitologic diagnosis","volume":"38","author":"JR Ramirez","year":"2000","journal-title":"J Clin Microbiol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.colsurfb.2015.12.003","article-title":"Topical amphotericin B in ultradeformable liposomes: Formulation, skin penetration study, antifungal and antileishmanial activity in vitro","volume":"139","author":"AP Perez","year":"2016","journal-title":"Colloids Surf B Biointerfaces"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.colsurfb.2015.07.032","article-title":"Topical Amphotericin B solid lipid nanoparticles: Design and development","volume":"139","author":"D Butani","year":"2016","journal-title":"Colloids Surf B Biointerfaces"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.ejpb.2008.05.008","article-title":"Lipid nanoparticles as vehicles for topical psoralen delivery: solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC)","volume":"70","author":"JY Fang","year":"2008","journal-title":"Eur J Pharm Biopharm"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1039\/C5CS00674K","article-title":"New approaches from nanomedicine for treating leishmaniasis","volume":"45","author":"V Gutierrez","year":"2016","journal-title":"Chem Soc Rev"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"e0149697","DOI":"10.1371\/journal.pone.0149697","article-title":"The Cure Rate after Placebo or No Therapy in American Cutaneous Leishmaniasis: A Systematic Review and Meta-Analysis","volume":"11","author":"GF Cota","year":"2016","journal-title":"PLoS One"}],"updated-by":[{"DOI":"10.1371\/journal.pntd.0006653","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2018,8,6]],"date-time":"2018-08-06T00:00:00Z","timestamp":1533513600000}}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0006653","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,6]],"date-time":"2020-11-06T18:14:42Z","timestamp":1604686482000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0006653"}},"subtitle":[],"editor":[{"given":"Alejandro","family":"Llanos-Cuentas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,7,25]]},"references-count":26,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2018,7,25]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0006653","relation":{"new_version":[{"id-type":"doi","id":"10.1371\/journal.pntd.0006653","asserted-by":"object"}]},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,25]]}}}